Literature DB >> 28663680

Hepatocellular Carcinoma: An Unusual Complication of Longstanding Wilson Disease.

Deepak Gunjan1, Neeti Nadda2, Saurabh Kedia2, Baibaswata Nayak2, Shashi B Paul3, Shivanand Ramachandra Gamanagatti3, Subrat K Acharya2.   

Abstract

Wilson disease is caused by the accumulation of copper in the liver, brain or other organs, due to the mutation in ATP7B gene, which encodes protein that helps in excretion of copper in the bile canaliculus. Clinical presentation varies from asymptomatic elevation of transaminases to cirrhosis with decompensation. Hepatocellular carcinoma is a known complication of cirrhosis, but a rare occurrence in Wilson disease. We present a case of neurological Wilson disease, who later developed decompensated cirrhosis and hepatocellular carcinoma.

Entities:  

Keywords:  ALP, alkaline phosphatise; ALT, alanine aminotransferase; ANA, anti-nuclear antibody; ASMA, anti-smooth muscle antibody; AST, aspartate aminotransferase; Barcelona clinic liver cancer (BCLC) staging; HCC, hepatocellular carcinoma; MPCT, multiphasic computed tomography; SAAG, serum-ascites albumin gradient; TACE, trans-arterial chemo-embolization; anti-LKM1, anti-liver kidney microsomal antibody type1; cirrhosis; d-penicillamine; decompensation

Year:  2016        PMID: 28663680      PMCID: PMC5478940          DOI: 10.1016/j.jceh.2016.09.012

Source DB:  PubMed          Journal:  J Clin Exp Hepatol        ISSN: 0973-6883


  12 in total

1.  Hepatobiliary malignancies in Wilson disease.

Authors:  Jan Pfeiffenberger; Carolin Mogler; Daniel N Gotthardt; Henning Schulze-Bergkamen; Thomasz Litwin; Ulrike Reuner; Harald Hefter; Dominik Huster; Peter Schemmer; Anna Członkowska; Peter Schirmacher; Wolfgang Stremmel; David Cassiman; Karl Heinz Weiss
Journal:  Liver Int       Date:  2014-11-23       Impact factor: 5.828

2.  Thiamine supplementation attenuated hepatocellular carcinoma in the Atp7b mouse model of Wilson's disease.

Authors:  Christian T Sheline
Journal:  Anticancer Res       Date:  2011-10       Impact factor: 2.480

Review 3.  Genetic aspects of Wilson's disease.

Authors:  M Frydman
Journal:  J Gastroenterol Hepatol       Date:  1990 Jul-Aug       Impact factor: 4.029

4.  Effect of penicillamine and zinc on iron metabolism in Wilson's disease.

Authors:  Valentina Medici; Vincenza Di Leo; Francesca Lamboglia; Christopher L Bowlus; Szu-Ching Tseng; Renata D'Incà; Paola Irato; Patrizia Burra; Diego Martines; Giacomo C Sturniolo
Journal:  Scand J Gastroenterol       Date:  2007-12       Impact factor: 2.423

Review 5.  Wilson's disease.

Authors:  Aftab Ala; Ann P Walker; Keyoumars Ashkan; James S Dooley; Michael L Schilsky
Journal:  Lancet       Date:  2007-02-03       Impact factor: 79.321

6.  Diagnosis and treatment of Wilson disease: an update.

Authors:  Eve A Roberts; Michael L Schilsky
Journal:  Hepatology       Date:  2008-06       Impact factor: 17.425

7.  Hepatic iron deprivation prevents spontaneous development of fulminant hepatitis and liver cancer in Long-Evans Cinnamon rats.

Authors:  J Kato; M Kobune; Y Kohgo; N Sugawara; H Hisai; T Nakamura; S Sakamaki; N Sawada; Y Niitsu
Journal:  J Clin Invest       Date:  1996-08-15       Impact factor: 14.808

8.  Severe dysfunction of respiratory chain and cholesterol metabolism in Atp7b(-/-) mice as a model for Wilson disease.

Authors:  Sven W Sauer; Uta Merle; Silvana Opp; Dorothea Haas; Georg F Hoffmann; Wolfgang Stremmel; Jürgen G Okun
Journal:  Biochim Biophys Acta       Date:  2011-09-02

9.  No increased risk of hepatocellular carcinoma in cirrhosis due to Wilson disease during long-term follow-up.

Authors:  Suzanne van Meer; Robert A de Man; Aad P van den Berg; Roderick H J Houwen; Francisca H H Linn; Martijn G H van Oijen; Peter D Siersema; Karel J van Erpecum
Journal:  J Gastroenterol Hepatol       Date:  2015-03       Impact factor: 4.029

10.  Abdominal malignancies in patients with Wilson's disease.

Authors:  J M Walshe; E Waldenström; V Sams; H Nordlinder; K Westermark
Journal:  QJM       Date:  2003-09
View more
  6 in total

Review 1.  Connecting copper and cancer: from transition metal signalling to metalloplasia.

Authors:  Eva J Ge; Ashley I Bush; Angela Casini; Paul A Cobine; Justin R Cross; Gina M DeNicola; Q Ping Dou; Katherine J Franz; Vishal M Gohil; Sanjeev Gupta; Stephen G Kaler; Svetlana Lutsenko; Vivek Mittal; Michael J Petris; Roman Polishchuk; Martina Ralle; Michael L Schilsky; Nicholas K Tonks; Linda T Vahdat; Linda Van Aelst; Dan Xi; Peng Yuan; Donita C Brady; Christopher J Chang
Journal:  Nat Rev Cancer       Date:  2021-11-11       Impact factor: 69.800

Review 2.  Selective Targeting of Cancer Cells by Copper Ionophores: An Overview.

Authors:  Valentina Oliveri
Journal:  Front Mol Biosci       Date:  2022-03-04

3.  The prognostic value and immune landscape of a cuproptosis-related lncRNA signature in head and neck squamous cell carcinoma.

Authors:  Yao Jun Li; Hai Yan Li; Quan Zhang; Sheng Li Wei
Journal:  Front Genet       Date:  2022-07-22       Impact factor: 4.772

4.  Prognostic Implication of a Cuproptosis-Related miRNA Signature in Hepatocellular Carcinoma.

Authors:  Ze Jin; Mengmeng Wang; Yajun Meng; Di Chen; Yushuang Xu; Xin Jiang; Zhifan Xiong
Journal:  J Healthc Eng       Date:  2022-09-13       Impact factor: 3.822

5.  Relationships of Cuproptosis-Related Genes With Clinical Outcomes and the Tumour Immune Microenvironment in Hepatocellular Carcinoma.

Authors:  Xi Chen; Gang Hu; Li Xiong; Qingqing Xu
Journal:  Pathol Oncol Res       Date:  2022-09-21       Impact factor: 2.874

6.  A novel cuproptosis-related prognostic lncRNA signature for predicting immune and drug therapy response in hepatocellular carcinoma.

Authors:  Shujia Chen; Peiyan Liu; Lili Zhao; Ping Han; Jie Liu; Hang Yang; Jia Li
Journal:  Front Immunol       Date:  2022-09-15       Impact factor: 8.786

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.